Trump launches 'TrumpRx' to slash drug prices — and even brings Pfizer on board



President Trump announced earlier this week his effort aimed at lowering drug costs, which includes the creation of a “TrumpRx” website, where Americans can buy medicine at a discount — and somehow got Pfizer to agree to join him.

“The United States is done subsidizing the health care of the rest of the world,” Trump said. “By taking this bold step, we’re ending the era of global price gouging at the expense of American families.”

Surprisingly, Pfizer is the first pharmaceutical company to comply with Trump’s demands, which include selling drugs to Medicaid and setting prices of new drugs at “Most-Favored Nation” levels, which is the lowest price available in other countries.

BlazeTV host Stu Burguiere is surprised by the move.


“This is interesting to me for a bunch of different reasons,” Burguiere tells BlazeTV host Dave Landau. “First of all, as a conservative, I don’t really like the idea of the government being involved in these things, but there are, you know, real concerns with drug prices on certain things.”

“The other thing I find fascinating about it, is like a big chunk of Donald Trump’s base thinks Pfizer is the Nazi regime. Literally hates this company more than anything else. And what I find fascinating about it is Trump can just do this stuff,” he continues.

“He’s the only guy I’ve ever seen that can just do this stuff. He can embrace a company that his base hates and somehow just go right down the middle unscathed,” he adds.

Want more from Stu?

To enjoy more of Stu's lethal wit, wisdom, and mockery, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution, and live the American dream.

'TrumpRx' website to offer discounted drugs as part of landmark Big Pharma deal



President Donald Trump unveiled a new deal to drastically reform the pharmaceutical industry and reduce drug prices for consumers.

Trump announced that Pfizer would be heavily discounting some of its "most popular medications" and that all new medications introduced in the U.S. markets would be sold at the "reduced Most Favored Nation cost." Trump also revealed that these discounted drugs will be available for purchase on a federally operated "TrumpRx" direct-to-consumer website.

'The big winner of this deal clearly will be the American patient.'

"It's going to have a huge impact on bringing Medicaid costs down, like nothing else. ... Especially, low-income Americans will be helped so greatly," Trump said in the Oval Office Tuesday.

"This is a consequential moment for our country," press secretary Karoline Leavitt said in a post on X. "Drug prices WILL be lower for everyday Americans, thanks to the negotiating prowess and determination of President Donald J. Trump. Democrats have been wanting to do this for decades. The Trump Administration has delivered."

RELATED: Health organizations attacking Trump's Tylenol-autism claims are cozied up with Big Pharma

pic.twitter.com/WGVNZLGsZS
— Rapid Response 47 (@RapidResponse47) September 30, 2025

Trump initially issued an executive order in May that directed drug companies to offer the "most-favored-nation" price for American patients. If they failed to do so, the Department of Health and Human Services would make a rule to implement the policy, and the Food and Drug Administration would revoke approvals for drugs that may be "unsafe, ineffective, or improperly marketed."

Trump also wrote to over a dozen major pharmaceutical CEOs in July demanding that the manufacturers voluntarily extend the "most-favored-nation" pricing to all medicines provided to Medicaid recipients. Trump gave these companies until Monday to formally respond.

"If you refuse to step up, we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices," Trump wrote.

So far, Eli Lilly pledged to raise prices in Europe in order to lower costs in the United States. Bristol-Myers Squibb similarly plans to charge the same list price for a new schizophrenia treatment in both the United States and United Kingdom.

RELATED: Who is bankrolling the anti-MAHA movement?

Photo by Win McNamee/Getty Images

"The big winner of this deal clearly will be the American patient. There's no doubt about it," Pfizer CEO Albert Bourla said during the press conference. "They are the ones that will see significant impact in their ability to buy medicines."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Louisiana seeks arrest of California doctor accused of sending abortion pills to the Bayou State



The Bayou State has reportedly issued an arrest warrant for a Northern California doctor accused of sending abortion pills to a Louisiana woman in 2023 — a woman who has indicated she was pressured to take the drugs and is now "haunt[ed]" by her chemical abortion.

"On multiple occasions, I have raised concerns about the unlawful distribution of these pills in our sate and the harm that it does to women," Louisiana Attorney General Liz Murrill said in a statement. "It’s dangerous, irresponsible, unethical, and illegal to distribute these pills to strangers in violation of the criminal laws of our state, without any relationship whatsoever to the individual who may ultimately be consuming them."

'I would have told the doctor that I wanted to keep my baby.'

"I will enforce and defend the laws of our state, including suing the governors whose shield laws purport to protect these individuals from criminal conduct in Louisiana," added Murrill.

The warrant for Remy Coeytaux's arrest is the latest action in a broader battle between red and blue states over federal approvals for mifepristone — an abortion drug that the U.S. Food and Drug Administration has indicated is linked to a number of serious adverse events as well as the deaths of dozens of mothers.

Rosalie Markezich, the recipient of the drug who is now "haunt[ed]" by her chemical abortion, has joined Louisiana Attorney General Liz Murrill in requesting to join a lawsuit aimed at prompting the FDA to prohibit telehealth prescriptions to mifepristone. Texas and Florida are similarly keen to get involved in the lawsuit that was revived last year by Missouri, Kansas, and Idaho.

Markezich claimed in a court filing earlier this month that despite initially celebrating her pregnancy, her boyfriend "soon changed his mind," then used her personal email address and mailing address to obtain mifepristone and misoprostol "from an online provider that his sister has used multiple times before."

RELATED: The abortion pill’s body count — and the progressive cover-up behind it

Louisiana Attorney General Liz Murrill. Photo by Chris Graythen/Getty Images

A few days after allegedly forwarding to Remy Coeytaux the $150 her boyfriend sent her, Markezich received the drugs by mail.

According to her declaration, Markezich changed her mind about killing her child, but her boyfriend, who apparently "had anger issues and a criminal record," allegedly coerced her into taking them — and she proved unable to throw them back up.

"The trauma of my chemical abortion still haunts me," said Markezich. "Had the FDA required an in-person visit with a doctor before dispensing the drugs, my boyfriend would never [have] been able to obtain the drugs that he made me take. I also would have told the doctor that I did not want to take them. And I would have told the doctor that I wanted to keep my baby."

'Safeguards for women regarding the administration of mifepristone have been significantly reduced.'

Murrill, who has not elaborated on what charges Coeytaux faces or when the warrant was issued, said in a statement to the Associated Press that Markezich is bravely representing many women "who are victimized by the illegal, immoral, and unethical conduct of these drug dealers."

Coeytaux, who did not immediately respond to the Associated Press' request for comment, is also named in a civil complaint filed in July with the federal court for the Southern District of Texas.

The Texas complaint, filed on behalf of Jerry Rodriguez, alleges that Rodriguez's girlfriend, Kendal Garza, became pregnant with his child but was ultimately pressured by her estranged husband to use abortion drugs allegedly obtained from Coeytaux "to murder Mr. Rodriguez's unborn child."

Weeks after the filing of Rodriguez's suit, Texas Attorney General Ken Paxton ordered Coeytaux to cease and desist from mailing abortion drugs into the state of Texas and indicated such conduct not only violates Texas state law but the federal Comstock Act of 1873, which prohibits the mailing of abortion-related drugs.

Whereas some red states have laws on the books enabling mothers to take legal action against out-of-state abortion drug pushers, several Democrat-run states — including California, as of Friday — have passed laws shielding abortion-pill peddlers from legal consequence for violating other states' abortion bans.

While the multi-state lawsuit that Markezich and Murrill seek to join could end up resolving this conflict, the Trump administration may end up deciding independently to impose restrictions on mifepristone prescriptions.

Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Martin Makary reportedly told Republican state attorneys general in a Sept. 19 letter that the Department of Health and Human Services was conducting a safety review of the abortion drug.

"Recent studies — such as the study by the Ethics and Public Policy Center (EPPC), which you highlighted in your letter — indicate potential dangers that may attend offering mifepristone without sufficient medical support or supervision," said the letter. "FDA's own data collected between 2000 to 2012 indicated 2,740 adverse events, including 416 events involving blood loss requiring transfusions. Since then, safeguards for women regarding the administration of mifepristone have been significantly reduced."

A coalition of 20 Democratic attorneys general cited Kennedy's letter in a joint statement on Monday where they noted, "If access to mifepristone is challenged, we will take action to protect it."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

EXCLUSIVE: ‘It Makes Them Go Nuts’ — Candidate Daniel Keenan Vows To Target Big Pharma For Creating Trans Shooters

'We really need to get to the root problem'

Time to fight: Medical 'experts' want to jab a needle through your God-given rights



The American Academy of Pediatrics, like other institutional medical organizations, demands respect and submission to its pronouncements about public health.

The AAP is extraordinarily influential — perhaps even more powerful than the American Medical Association — because it asserts itself as the authority on our children's health. The reason it wields more power is because parents — especially first-time parents, even if they're willing to question "medical authorities" in general — often fold like a cheap suit at the disapproving frown of their own pediatrician.

That's what makes the latest power play from the AAP especially revolting.

The AAP is unquestionably political and firmly left-wing. Its stance on the ridiculously named "gender-affirming care" is proof.

"The science still supports gender-affirming care; children will still need it," Dr. Susan Kressly, president of the AAP, said this year. "The American Academy of Pediatrics remains unwavering in our support for transgender and gender-diverse youth and their access to the same standard of compassionate, evidence-based care as every other child."

Now, the AAP is going to war against states that allow religious exemptions for childhood vaccines, framing its stand as a "public health" issue.

Religious gurus?

To make its argument against religious exemptions to vaccines, the AAP essentially deems itself a source of theological and doctrinal experts.

The AAP said recently:

Among the major world religious traditions, none include scriptural or doctrinal guidelines that preclude adherents from being vaccinated. Just as with other types of doctrines, those related to vaccines might even be developed by small communities or individuals in ways that are completely independent from antecedent scriptural or doctrinal traditions but are, nonetheless, thought of as “religious” commitments by those who hold them.

In other words, the AAP believes that only dumb hicks from small towns believe their faith should inform how they, as parents, care for their children.

It's sheer arrogance. But not only that, I don't think parents should listen to the AAP, because its moral authority on the matter of childhood vaccines is compromised — at best.

Protecting pediatricians — not children

Health and Human Services Secretary Robert F. Kennedy Jr. revealed this year that thousands of physicians had Medicare reimbursements altered based on childhood vaccination rates. He called it coercion. Others call it corruption. But there is no dispute that pediatricians receive financial incentives for increased vaccine uptake, sometimes amounting to many thousands of dollars a year.

Until pediatricians stop financially benefiting from a patient's choice to use Big Pharma's products, their advice must be examined with considerable suspicion.

The larger reason to dismiss the AAP is that, thanks to the Make America Healthy Again movement, vaccines are finally under well-deserved scrutiny. Research questioning the safety and efficacy of vaccines has existed for years, but it has been actively suppressed by Big Medicine and Big Pharma.

RELATED: Jab first, ask questions later: Vaccine truths your doctor won't tell you

SementsovaLesia/iStock/Getty Images Plus

As more research comes out, the childhood vaccine schedule is not looking good. Even President Donald Trump is questioning it. The AAP and other similar organizations unforgivably ignore these facts as they seek to protect their fiefdom over vulnerable young parents and their even more vulnerable babies.

Make no mistake: The AAP doesn't want your kids to be able to go to school unless you inject them with highly questionable and unnecessary substances (a great reason for homeschooling, if you ask me) — and your pediatrician will likely push you hard in that same direction.

I know all about that. I'm an original MAHA mom who visited the pediatrician armed with a list of vaccine questions over 30+ years ago. That doctor was arrogant, dismissive, refused to answer them, and told me I'd be sorry when my child died.

But my child did not die. She is still alive and thriving, more than three decades later.

Vaccines 101

If this is new to you — or if you're unsure of your own convictions — the rest of this essay will help you.

The starter information that I've compiled below — some very practical, some philosophical (even more important for a strong foundation) — is especially designed for soon-to-be parents, friends who are terrified to go against a pediatrician's advice, or anyone else who has not yet seen through the lies we've been fed for so very long.

However, be warned: Once you start down this rabbit trail, your faith in the medical establishment may be shaken so hard you'll realize that, ultimately, you are responsible for your family's health. No pediatrician or medical organization — like the self-important, misinformed AAP pontificating about our faith traditions — have your child's best interests at heart the way you do.

But take courage. There's a world of information and support out here. Arm yourself with as much of it as possible.

Trust in the medical industry is at an all-time low — and for good reason. They blame everyone but themselves — like the AAP targeting religious people — but the problem isn't our lack of trust.

The problem is their lack of transparency. And not only is the medical industry not transparent, but the "experts" seem unwilling to consider solutions and ideas found outside of Big Medicine and Big Pharma. They think they know best, but they're woefully uneducated on nutrition, movement, light, and other well-known natural remedies.

Ironically, these same people should be at the forefront of vaccine transparency because they claim to be guided by "science" and "truth." And yet, they want to lecture us about our faith.

Now is the time to take back control of our health with professional healers who work with our bodies — not against them. That's the philosophy we must adopt, whether we're "religious" or not.

Tylenol's concerns about possible autism risk date back more than a decade, documents reportedly show



Medical groups, foreign health organizations, and some lawmakers threw a conniption this week after President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. dared to take action over the apparent association between autism and prenatal exposure to acetaminophen, the active ingredient in Tylenol.

A popular tactic taken by critics was to refute a claim the Trump administration wasn't making, namely that acetaminophen was causally linked to autism.

The American College of Obstetricians and Gynecologists, for example, stated, "In more than two decades of research on the use of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the use of acetaminophen in any trimester of pregnancy causes neurodevelopmental disorders in children."

Of course, the point the administration was making concerns the apparent correlation, not causation, between Tylenol use during pregnancy and autism in children — a correlation that has been borne out in numerous studies published in reputable peer-reviewed scientific journals such as Environmental Health, JAMA Psychiatry, Clinical and Experimental Pediatrics, and the International Journal of Epidemiology.

While such studies evidently have not swayed organizations cozy with the pharmaceutical industry, they certainly caused alarm behind the scenes at the very company that made Tylenol for six decades.

Pharmaceutical giant Johnson & Johnson made the acetaminophen product Tylenol available over the counter in 1960. In 2023, J&J spun off its consumer health care division Kenvue as an independent company, which now makes the drug.

Damning internal documents recently obtained by the Daily Caller indicate that years before J&J parted ways with Tylenol, some of its senior scientists admitted that a possible association existed between Tylenol and autism.

RELATED: Fact-check: Tylenol confirms 2017 pregnancy warning tweet is authentic

Photo Illustration by Justin Sullivan/Getty Images

For instance, when serving as the U.S. director of epidemiology for J&J's pharmaceutical arm Janssen in 2018, Rachel Weinstein noted in an email, "The weight of evidence is starting to feel heavy to me."

After referencing "studies in prenatal exposure and neurodev outcome," Weinstein wrote, "It looks like there are a bunch of papers from 2016 that we somehow missed. Many of them by Liew et al."

One of the papers Weinstein may have been referring to was a study published in the international journal Autism Research. The study indicated that maternal use of acetaminophen for over 20 weeks of pregnancy "increased the risk of [autism spectrum disorder] or infantile autism with hyperkinetic symptoms almost twofold."

The company documents were provided to the Caller by the law firm Keller Postman, which is leading a class-action lawsuit against Kenvue as well as against retailers that sell their own store-branded acetaminophen.

Ashley Keller, lead attorney for the families whose suit will be heard before the Court of Appeals for the Second Circuit beginning on Oct. 9, told Blaze News, "The emails confirm that the company's nothing-to-see-here response to the administration's announcement is pure spin."

"Internally, the company was aware of the growing body of scientific evidence linking prenatal Tylenol use to neurodevelopmental harm in offspring," Keller added.

'There are dozens of studies showing a link between Tylenol and neurodevelopmental harm in offspring.'

Weinstein wrote in a 2014 letter to one of the researchers behind the 2014 study titled "Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders," which was published in JAMA Pediatrics, "We recognize the substantial strengths of the study and the data sources."

That study concluded, "Maternal acetaminophen use during pregnancy is associated with a higher risk for HKDs and ADHD-like behaviors in children."

Referencing her correspondence with the researcher on the 2014 paper, Weinstein and other top J&J scientists considered backing follow-up studies; however, she then noted, "Do we really need to stick our neck out and make this offer?"

Slides for a 2018 internal presentation labeled "privileged and confidential" discussed epidemiological studies concerning potential links between Tylenol and various neurodevelopmental disorders. The slide summarizing the studies under review states, "Individual observational studies show a somewhat consistent association of increased occurrence of neurodevelopmental outcomes with prenatal exposure."

Internal communications further indicate that some J&J employees were reportedly also aware of a 2018 scientific review that indicated nine recent studies had suggested "an increased risk of adverse neurodevelopmental outcomes following prenatal [acetaminophen] exposure."

The Caller indicated that Weinstein could not be reached for comment.

A spokesperson for J&J told the Daily Caller, "Johnson & Johnson divested its consumer health business years ago, and all rights and liabilities associated with the sale of its over-the-counter products, including Tylenol (acetaminophen), are owned by Kenvue."

The current maker of Tylenol, Kenvue, in turn continued downplaying a link between its drug and autism.

"Nothing is more important to us than the health and safety of the people who use our products," said Kenvue spokeswoman Melissa Witt. "We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism."

When asked about Kenvue's assertion that "there is no credible science that shows taking acetaminophen causes autism," Keller, the attorney representing families in the class-action lawsuit against Kenvue, told Blaze News, "To quote the late, great Justice Scalia: 'Pure applesauce.'"

Alluding to some of the credible science that has been undertaken to date, Keller underscored there is cause for concern.

"There are dozens of studies showing a link between Tylenol and neurodevelopmental harm in offspring. The direct measurement studies that look at biomarkers all show dose response (more Tylenol, more risk)," Keller said. "They also show very elevated odds ratios (double, triple, quadruple, even quintupling of the risk). The animal models, which can control for genetics far better than human observational studies, show that acetaminophen is neurotoxic."

"Does that mean causation has been definitively established? No, it is simply likely," Keller continued. "But even if you only think it is plausible, we shouldn't have to wait for definitive proof of causation before we warn pregnant women of risks."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Health organizations attacking Trump's Tylenol-autism claims are cozied up with Big Pharma



Medical establishmentarians have come out of the woodwork to condemn the Trump administration's recent autism announcement. Although these health organizations dispute the administration's findings from a medical perspective, many of them omit their close ties to pharmaceutical companies.

President Donald Trump and Health Secretary Robert F. Kennedy Jr. sparked outrage among the medical establishment by formally naming acetaminophen, the active ingredient in Tylenol, as one of the alleged culprits behind the exponential increase of autism in American children.

'The Trump administration does not believe popping more pills is always the answer.'

Trump and Kennedy's announcement suggested that pregnant women who take acetaminophen could be at an increased risk of having children with neurological conditions like autism and ADHD. Kennedy also indicated that the U.S. Food and Drug Administration will notify physicians of the findings and that the Department of Health and Human Services will launch a nationwide campaign to inform parents of the potential risks.

"For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary," Trump said during the Monday announcement.

RELATED: Who is bankrolling the anti-MAHA movement?

Photo by Andrew Harnik/Getty Images

"The Trump administration does not believe popping more pills is always the answer for better health," press secretary Karoline Leavitt said in a statement. "There is mounting evidence finding a connection between acetaminophen use during pregnancy and autism — and that’s why the administration is courageously issuing this new health guidance."

A slew of medical organizations quickly came out against the findings, saying they are "filled with dangerous claims" and "irresponsible." At the same time, some of these same organizations have cozied up to pharmaceutical companies.

RELATED: Libs gobble Tylenol, foreign officials complain after Trump highlights autism link

Daniel Acker/Bloomberg via Getty Images

The American Psychiatric Association cautioned against the White House announcement, saying it was "incorrect to imply that a handful of studies have established causation."

"A strong base of evidence shows that acetaminophen, when taken as directed, is safe for use during pregnancy," the APA said in a statement. "Any decisions around a course of treatment should be determined by a patient and their doctor."

One of the many notable "patrons" that supports the APA Foundation includes Johnson & Johnson, which owned the Tylenol brand for decades before Kenvue took ownership in 2023. Other patrons include Alkermes, which produces a drug that is being tested for efficacy in treating autism, and Sage Therapeutics, which also has a drug development program to treat conditions like autism.

Other groups like the American College of Obstetricians and Gynecologists as well as the American Academy of Pediatrics have issued similar statements criticizing the administration's autism announcement.

RELATED: Trump administration claims link between autism and Tylenol, greenlights remedy

Photo by Mario Tama/Getty Images

"Today’s White House event on autism was filled with dangerous claims and misleading information that sends a confusing message to parents and expecting parents and does a disservice to autistic individuals," the AAP said in a statement.

"Suggestions that acetaminophen use in pregnancy causes autism are not only highly concerning to clinicians but also irresponsible when considering the harmful and confusing message they send to pregnant patients, including those who may need to rely on this beneficial medicine during pregnancy," the ACOG said in a statement.

Although the ACOG does not appear to have directly received funding from pharmaceutical companies, several have been listed as "supporters" of the organization. Meanwhile, the AAP's "Presidential Circle," which is made up of corporations that have donated $50,000 or more, includes household pharmaceutical companies like Pfizer and Moderna. The "Patron" donors list, which includes donations between $25,000 and $49,000, also includes Eli Lily and Genentech as partners.

The APA, the AAP, and the ACOG did not immediately respond to a request for comment from Blaze News.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Fact-check: Tylenol confirms 2017 pregnancy warning tweet is authentic



President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. announced on Monday that the U.S. Food and Drug Administration will notify physicians that acetaminophen use by pregnant women may be associated with a "very increased risk" of neurological conditions like autism and ADHD in children.

This announcement prompted debate about the safety of acetaminophen, which is the active ingredient in Tylenol and the leading cause of acute livery injury in the United States.

'If pregnant or breast-feeding, ask a health professional before use.'

Amid efforts to downplay possible risks of Tylenol usage during pregnancy by medical professionals and by foreign health organizations, online sleuths uncovered old yet thematically relevant messages Tylenol apparently shared on social media. Two of those messages went viral this week.

The first tweet, which is dated June 17, 2019, states, "Congrats on your upcoming addition! SO exciting! It'd be great to touch base real quick since we haven't tested Tylenol to be used during pregnancy."

The second tweet, dated March 7, 2017, states, "We actually don't recommend using any of our products while pregnant. Thank you for taking the time to voice your concerns today."

The second tweet was reposted on X both by the White House, with an image of Trump holding a hat emblazoned with the message, "Trump was right about everything," and by the Department of Health and Human Services with the caption, "No caption needed."

— (@)

Some social media users expressed doubt that Tylenol was actually responsible for the original tweet; others seized on the tweet as validation of the president's recent warnings about taking acetaminophen; and a few claimed it was being grossly misinterpreted.

Fact: The tweet is authentic.

When asked about the tweet, a spokesperson for Kenvue, the maker of Tylenol, told Blaze News, "This post from 2017 is being taken out of context."

"We do not recommend pregnant women take any medication without talking to their doctor," continued the statement. "This is consistent with the regulations and product label for acetaminophen."

Screenshot of correspondence with Kenvue.

This messaging is consistent with what appeared on the drug's warning label as of 2019.

In addition to highlighting the risk of "severe skin reactions" and "severe liver damage" if taken in excess or in conjunction with certain other substances, the packaging states: "If pregnant or breast-feeding, ask a health professional before use."

RELATED: Trump administration claims link between autism and Tylenol, greenlights remedy

Photo Illustration by Justin Sullivan/Getty Images

Similar language appeared in a Feb. 13, 2017, tweet in which Tylenol wrote, "Just make sure to talk to your doctor before taking Tylenol while you're pregnant."

When asked whether Tylenol poses an elevated risk to pregnant women and/or their unborn children and why pregnant women need to consult their doctors prior to use, a spokesperson for Kenvue, formerly the consumer health care division of Johnson & Johnson, provided the following response to Blaze News:

"The post did not address the full guidance — which has not changed:

  • "Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy.
  • "Our products are safe and effective when used as directed on the product label.
  • "We recommend pregnant women do not take any over-the-counter medication, including acetaminophen, without talking to their doctor first."

Tylenol's updated frequently asked questions webpage has a section on acetaminophen and autism, which states: "Our best advice? Talk to your healthcare professional before taking or administering acetaminophen."

The FAQ also states: "Please know that there is no credible science that shows taking acetaminophen causes autism."

'The majority of the studies reported positive associations of prenatal acetaminophen use with ADHD, ASD, or NDDs in offspring.'

There has long been evidence of an association between prenatal acetaminophen exposure and neurodevelopmental disorders including autism — an association the American College of Obstetricians and Gynecologists and some of the other outfits now defending Tylenol once admitted.

For example:

  • A 2013 HHS-backed study published in the International Journal of Epidemiology concluded that "children exposed to long-term use of paracetamol during pregnancy had substantially adverse developmental outcomes at 3 years of age."
  • A 2017 study published in the Journal of International Medical Research said, "The bottom line is that hundreds of studies describing the epidemiology of autism and the numerous and varied risk factors for autism have a straightforward explanation: autism could be an acetaminophen-induced brain injury facilitated by oxidative stress and inflammation in newborns and young children."
  • A National Institutes of Health-funded 2019 study published in the journal JAMA Psychiatry indicated that "[umbilical] cord biomarkers of fetal exposure to acetaminophen were associated with significantly increased risk of childhood ADHD and ASD in a dose-response fashion."
  • A 2023 scientific review published in the Swiss journal Children concluded "without reasonable doubt and with no evidence to the contrary that exposure of susceptible babies and children to acetaminophen (paracetamol) induces many, if not most, cases of autism spectrum disorder."
  • A 2024 study published in the journal Clinical and Experimental Pediatrics noted that "careful examination reveals no valid objections to the conclusion that early exposure to acetaminophen causes neurodevelopmental injury in susceptible babies and children."
  • An NIH-supported systematic review published last month in the medical journal Environmental Health noted on the basis of an analysis of scores of studies regarding the relationship between neurodevelopmental disorders, including autism and attention-deficit/hyperactivity disorder, and prenatal exposure to acetaminophen, that "overall, the majority of the studies reported positive associations of prenatal acetaminophen use with ADHD, ASD, or NDDs in offspring, with risk-of-bias and strength-of-evidence ratings informing the overall synthesis."
"Don't take Tylenol," Trump said on Monday. "Fight like hell not to take it."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Critics uncover Tylenol's cautionary tweet for pregnant moms after Trump highlights autism link



President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. have formally identified acetaminophen, the active ingredient in Tylenol, as one of the alleged drivers behind the rise in American autism.

On Monday, Kennedy indicated that the U.S. Food and Drug Administration will notify physicians that acetaminophen use by pregnant women may be associated with a "very increased risk" of neurological conditions like autism and ADHD in children. The label on the drug will henceforth reflect this understanding.

'We haven't tested Tylenol to be used during pregnancy.'

Following the announcement, liberals began gobbling fistfuls of pills in protest, and foreign health officials rushed to convince the public of acetaminophen's safety and efficacy.

Meanwhile, some critics scrutinized previous advisories and messaging regarding Tylenol. One of the messages that some sleuths evidently came across has gone viral.

Tylenol tweeted on March 7, 2017, "We actually don't recommend using any of our products while pregnant. Thank you for taking the time to voice your concerns today."

RELATED: Libs gobble Tylenol, foreign officials complain after Trump highlights autism link

Photo by Chip Somodevilla/Getty Images

Whereas in at least two other tweets on theme, Tylenol suggested that pregnant and/or nursing mothers should speak with their doctors before using the drug, this particular message contained no such nuance.

Numerous critics pointed to the tweet as possible confirmation that even the iconic brand advises against pregnant women taking acetaminophen.

"What an interesting thing to say so long ago," said one X user.

South African musician David Scott, better known as the Kiffness, noted, "Despite all the warnings, crazy pregnant women are potentially jeopardising their children's future for a couple likes on TikTok ... hope this helps some from reconsidering."

A spokesperson for Kenvue said in a statement to Blaze News, "This post from 2017 is being taken out of context."

"We do not recommend pregnant women take any medication without talking to their doctor," continued the statement. "This is consistent with the regulations and product label for acetaminophen."

When asked whether Tylenol poses an elevated risk to pregnant women and/or their unborn children and why pregnant women need to consult their doctor prior to use, a spokesperson for Kenvue told Blaze News that "acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy."

"Our products are safe and effective when used as directed on the product label," continued the spokesperson. "We recommend pregnant women do not take any over-the-counter medication, including acetaminophen, without talking to their doctor first."

Another tweet that has resurfaced this week was Tylenol's note to an expectant parent on June 17, 2019, where the company noted, "We haven't tested Tylenol to be used during pregnancy."

Numerous robust studies have suggested an association between acetaminophen use during pregnancy and neurodevelopmental disorders including autism.

Dr. William Parker, CEO of WPLab and visiting scholar at the University of North Carolina at Chapel Hill, an author on a number of such studies, recently told Blaze News:

The science tells us several things. Among the most important are: (a) Exposure of susceptible babies and children to acetaminophen (paracetamol) induces many, if not most, cases of autism spectrum disorder. b) Specific, invalid assumptions made when analyzing epidemiologic data have impeded recognition of the role of acetaminophen in the induction of autism.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Libs gobble Tylenol, foreign officials complain after Trump highlights autism link



President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. caused an uproar among medical establishmentarians and thin-skinned liberals on Monday by formally identifying acetaminophen as one of the alleged drivers behind the rise in American autism.

Acetaminophen, often sold under the brand Tylenol in the United States but known overseas as paracetamol, is the most common over-the-counter pain and fever medication used during pregnancy. Sales of the drug this year have an estimated value of $10.9 billion.

Kennedy indicated that the U.S. Food and Drug Administration will notify physicians that acetaminophen use by pregnant women may be associated with a "very increased risk" of neurological conditions like autism and ADHD in children.

The Department of Health and Human Services will also launch a nationwide public information campaign to alert parents and families to the possible risks of taking Tylenol during pregnancy.

— (@)

"The Trump administration does not believe popping more pills is always the answer for better health," said White House press secretary Karoline Leavitt. "There is mounting evidence finding a connection between acetaminophen use during pregnancy and autism — and that’s why the administration is courageously issuing this new health guidance."

Foreign health officials rushed to defend the drug, suggesting that it is safe and effective.

Alison Cave, chief safety officer of the United Kingdom's Medicines and Healthcare products Regulatory Agency, said in a statement, "There is no evidence that taking paracetamol during pregnancy causes autism in children."

RELATED: Trump administration claims link between autism and Tylenol, greenlights remedy

Photo Illustration by Justin Sullivan/Getty Images

"Paracetamol remains the recommended pain relief option for pregnant women when used as directed," added Cave.

The MHRA stressed further that patients should continue taking their pain medicines.

Steffen Thirstrup, the chief medical officer of the European Medicines Agency, also chimed in, stating that acetaminophen is an important option for treating pain or fever in pregnant women and that his agency's "advice is based on a rigorous assessment of the available scientific data, and we have found no evidence that taking paracetamol during pregnancy causes autism in children."

'Exposure of susceptible babies and children to acetaminophen (paracetamol) induces many, if not most, cases of autism spectrum disorder.'

Tarik Jasarevic, a spokesman for the World Health Organization, told reporters on Tuesday that while some studies have suggested an association between prenatal exposure to the drug and autism, "evidence remains inconsistent."

"If the link between acetaminophen and autism were strong, it would likely have been consistently observed across multiple studies," added Jasarevic.

James Cusack, the autistic chief executive of Autistica, a London-based autism research charity, told Nature, "There is no definitive evidence to suggest that paracetamol use in mothers is a cause of autism, and when you see any associations, they are very, very small."

Meanwhile, numerous liberals and other critics of the administration proved memers prophetic by downing fistfuls of acetaminophen as a form of protest.

While some of the pill-popping videos appear to have been recorded in jest, others are accompanied with humorless critiques of the administration's efforts to identify and tackle the root causes of autism.

Ahead of Trump's announcement on Monday, a spokesperson for Kenvue, the maker of Tylenol whose stock price took a nose dive on Monday, told Blaze News, "We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers."

When pressed about what the "sound science clearly shows," Dr. William Parker, CEO of WPLab and visiting scholar at the University of North Carolina at Chapel Hill, told Blaze News:

The science tells us several things. Among the most important are: (a) Exposure of susceptible babies and children to acetaminophen (paracetamol) induces many, if not most, cases of autism spectrum disorder. b) Specific, invalid assumptions made when analyzing epidemiologic data have impeded recognition of the role of acetaminophen in the induction of autism.

Dr. Parker also cited his 2023 scientific review published in the Swiss peer-reviewed journal Children that concluded that "the very early postpartum period poses the greatest risk for acetaminophen-induced ASD, and that nearly ubiquitous use of acetaminophen during early development could conceivably be responsible for the induction in the vast majority, perhaps 90% or more, of all cases of ASD."

RELATED: How MAHA can really save American lives

Photo by Nathan Posner/Anadolu via Getty Images

Dr. Yuelong Ji, an assistant professor at Peking University, told Blaze News, "Officials should indeed advise caution regarding the unnecessary use of acetaminophen during pregnancy."

Ji was among the researchers at the Johns Hopkins Bloomberg School of Public Health who collected umbilical cord blood from 996 births and measured the amount of acetaminophen and two of its byproducts in each sample.

According to the resultant National Institutes of Health-funded 2019 study published in the journal JAMA Psychiatry, "Cord biomarkers of fetal exposure to acetaminophen were associated with significantly increased risk of childhood ADHD and ASD in a dose-response fashion."

"These results highlight the need for careful consideration of its use during this critical period of brain development," Ji told Blaze News. "The potential mechanisms by which acetaminophen may affect the developing brain should be thoroughly investigated. Until this mechanism is better understood, it is prudent for health officials to adopt a cautious approach when advising pregnant individuals on acetaminophen use."

The White House's fact sheet concerning the president's Tylenol-autism claims and the FDA's relabeling of acetaminophen cites Parker's and Ji's studies as well as a recent NIH-supported systematic review that found positive associations of prenatal acetaminophen use with ADHD, ASD, or NDDs in offspring across dozens of high-quality studies.

It also cites the 2021 international consensus statement that recommends pregnant women "minimize exposure" to acetaminophen "by using the lowest effective dose for the shortest possible time."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!